Zimmer Biomet Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.Zimmer Biomet Holdings Inc. (ZBH) shares fell 1.54% to $89.72, marking its second consecutive day of losses amid a broader market decline. Despite the drop, ZBH outperformed some competitors like Johnson & Johnson and Stryker, though Medtronic rose slightly. The stock remains 17.15% below its 52-week high, with trading volume below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zimmer Biomet Holdings Inc. (ZBH) slipped 1.54% to $89.72 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.
This was the stock's second consecutive day of losses.
Zimmer Biomet Holdings Inc. closed 17.15% below its 52-week high of $108.29, which the company achieved on August 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 1.67% to $248.82, Medtronic PLC (MDT) rose 0.11% to $83.29, and Stryker Corp. (SYK) fell 0.23% to $319.14.
Trading volume (2.2 M) remained 158,158 below its 50-day average volume of 2.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-20-26 1709ET